BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37818230)

  • 1. 24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ.
    Grander C; Meyer M; Steinacher D; Claudel T; Hausmann B; Pjevac P; Grabherr F; Oberhuber G; Grander M; Brigo N; Jukic A; Schwärzler J; Weiss G; Adolph TE; Trauner M; Tilg H
    JHEP Rep; 2023 Nov; 5(11):100872. PubMed ID: 37818230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease.
    Sangineto M; Grabherr F; Adolph TE; Grander C; Reider S; Jaschke N; Mayr L; Schwärzler J; Dallio M; Moschen AR; Moschetta A; Sabbà C; Tilg H
    Liver Int; 2020 Jul; 40(7):1610-1619. PubMed ID: 32306456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-Norursodeoxycholic acid reshapes immunometabolism in CD8
    Zhu C; Boucheron N; Müller AC; Májek P; Claudel T; Halilbasic E; Baazim H; Lercher A; Viczenczova C; Hainberger D; Preglej T; Sandner L; Alteneder M; Gülich AF; Khan M; Hamminger P; Remetic J; Ohradanova-Repic A; Schatzlmaier P; Donner C; Fuchs CD; Stojakovic T; Scharnagl H; Sakaguchi S; Weichhart T; Bergthaler A; Stockinger H; Ellmeier W; Trauner M
    J Hepatol; 2021 Nov; 75(5):1164-1176. PubMed ID: 34242699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.
    Halilbasic E; Fiorotto R; Fickert P; Marschall HU; Moustafa T; Spirli C; Fuchsbichler A; Gumhold J; Silbert D; Zatloukal K; Langner C; Maitra U; Denk H; Hofmann AF; Strazzabosco M; Trauner M
    Hepatology; 2009 Jun; 49(6):1972-81. PubMed ID: 19475687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
    Sombetzki M; Fuchs CD; Fickert P; Österreicher CH; Mueller M; Claudel T; Loebermann M; Engelmann R; Langner C; Sahin E; Schwinge D; Guenther ND; Schramm C; Mueller-Hilke B; Reisinger EC; Trauner M
    J Hepatol; 2015 Apr; 62(4):871-8. PubMed ID: 25463533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of ethanol-induced
    Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
    Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
    Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
    Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.
    Dong Y; Wu Z; Gai Z; Han M
    J Appl Microbiol; 2023 Nov; 134(11):. PubMed ID: 37930723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
    Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
    Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis.
    Wei H; Yu C; Zhang C; Ren Y; Guo L; Wang T; Chen F; Li Y; Zhang X; Wang H; Liu J
    Biomed Pharmacother; 2023 Apr; 160():114308. PubMed ID: 36709599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liver.
    Trottier J; El Husseini D; Perreault M; Pâquet S; Caron P; Bourassa S; Verreault M; Inaba TT; Poirier GG; Bélanger A; Guillemette C; Trauner M; Barbier O
    J Biol Chem; 2010 Jan; 285(2):1113-21. PubMed ID: 19889628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
    Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
    J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury
    Pi A; Jiang K; Ding Q; Lai S; Yang W; Zhu J; Guo R; Fan Y; Chi L; Li S
    Front Pharmacol; 2021; 12():752148. PubMed ID: 34603062
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery of
    Sangineto M; Grander C; Grabherr F; Mayr L; Enrich B; Schwärzler J; Dallio M; Bukke VN; Moola A; Moschetta A; Adolph TE; Sabbà C; Serviddio G; Tilg H
    Gut Microbes; 2022; 14(1):2089006. PubMed ID: 35786161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
    Krones E; Eller K; Pollheimer MJ; Racedo S; Kirsch AH; Frauscher B; Wahlström A; Ståhlman M; Trauner M; Grahammer F; Huber TB; Wagner K; Rosenkranz AR; Marschall HU; Fickert P
    J Hepatol; 2017 Jul; 67(1):110-119. PubMed ID: 28242240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strain of
    Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
    World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.